TSH BIOPHARM CORPORATION LIMITED

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening

Conditions
Prostate Cancer
First Posted Date
2022-01-06
Last Posted Date
2022-01-06
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
200
Registration Number
NCT05180305
Locations
🇨🇳

Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan

Propafenone in the Treatment of Atrial Fibrillation

Not Applicable
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: Propafenone
First Posted Date
2018-09-17
Last Posted Date
2021-09-23
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
71
Registration Number
NCT03674658
Locations
🇨🇳

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

A TSHRN1201 Sub-study-To Evaluate the Effects of add-on Ranolazine on Exercise Tolerance and Angina Frequency

Not Applicable
Completed
Conditions
Angina
Interventions
Drug: Ranolazine
Drug: Placebos
First Posted Date
2018-01-17
Last Posted Date
2019-04-10
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
20
Registration Number
NCT03401502
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Zhongzheng Dist, Taiwan

Corever in the Treatment of Hypertension

Phase 3
Completed
Conditions
Hypertension
Interventions
Drug: Corever
First Posted Date
2015-05-04
Last Posted Date
2016-11-04
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
134
Registration Number
NCT02432937
Locations
🇨🇳

Hualien Tzu Chi Hospital, Hualien, Taiwan

🇨🇳

Chung Shan Medical University Hospital, Taichung, Taiwan

🇨🇳

Taipei Veterans General Hospital, Taipei, Taiwan

and more 5 locations

Extended-Release RANCAD in the Patients With Stable Angina Pectoris

Phase 3
Completed
Conditions
Stable Angina Pectoris
Interventions
Drug: RANCAD
First Posted Date
2014-11-19
Last Posted Date
2017-04-28
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
75
Registration Number
NCT02294942
Locations
🇨🇳

Mackay Memorial Hospital, Taipei City, Taiwan

🇨🇳

Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan

🇨🇳

Far Eastern Memorial Hospital, New Taipei city, Taiwan

and more 3 locations

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

Phase 4
Completed
Conditions
Essential Hypertension
Interventions
Drug: Amlodipine/Valsartan
First Posted Date
2014-02-10
Last Posted Date
2015-11-13
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
36
Registration Number
NCT02058446
Locations
🇨🇳

Taichung Veterans General Hospital, Taichung, Taiwan

DMTA07 Combine With Amlodipine Treatment in Patients With Hypertension

First Posted Date
2012-06-07
Last Posted Date
2015-11-13
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
111
Registration Number
NCT01614366
Locations
🇨🇳

E-DA Hospital, Kaohsiung, Taiwan

🇨🇳

Taichung Veterans General Hospital, Taichung, Taiwan

🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

and more 5 locations

Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients

Phase 3
Terminated
Conditions
Orthostatic Hypotension
Interventions
Drug: Placebo
Drug: Droxidopa
First Posted Date
2012-06-05
Last Posted Date
2013-03-13
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
25
Registration Number
NCT01612078
Locations
🇨🇳

Taipei Medical University Hospital, Taipei, Taiwan

ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

First Posted Date
2011-06-17
Last Posted Date
2011-06-17
Lead Sponsor
TSH Biopharm Corporation Limited
Target Recruit Count
226
Registration Number
NCT01375322
Locations
🇨🇳

Taichung Veterans General Hospital, Taichung, Taiwan

🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

🇨🇳

Far Eastern Memorial Hospital, Taipei, Taiwan

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy